<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Excise Tax on Designated Drugs; Procedural Requirements</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Excise Tax on Designated Drugs; Procedural Requirements</h1>
    <p class="timestamp">Published: 2023-10-02 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This document contains proposed regulations that would provide guidance on how taxpayers will report liability for the excise tax imposed on manufacturers, producers, or importers of certain designated drugs. The proposed regulations affect manufacturers, producers, and importers of designated drugs that sell such drugs during certain statutory periods. The proposed regulations also would except such tax from semimonthly deposit requirements.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Proposed Rule</p>
    <p><strong>Agency:</strong> Treasury Department, Internal Revenue Service</p>
    <p><strong>Document Number:</strong> 2023-21586</p>
    <p><strong>Publication Date:</strong> 2023-10-02</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/10/02/2023-21586/excise-tax-on-designated-drugs-procedural-requirements">https://www.federalregister.gov/documents/2023/10/02/2023-21586/excise-tax-on-designated-drugs-procedural-requirements</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-21586</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
